When longevity's biggest theories meet patients - LinkedIn
linkedin.com
The gap between longevity science's elegant theories and what actually helps patients survive longer reveals why lab breakthroughs so rarely become bedside treatments.
GeroscienceTranslational MedicineHallmarks of AgingEvidence-Based Medicine
Theory Briefing
- Geroscience is packed with promising mechanisms and pathways, but clinical medicine demands results over elegance.
- The translation gap between longevity theory and patient care exposes a classic bench-to-bedside failure in biology.
- Aging research's biggest frameworks — from senescence to mTOR inhibition — struggle to survive contact with real-world clinical trials.